RP
WST icon

Riverbridge Partners’s West Pharmaceutical WST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$83.9M Sell
383,520
-24,886
-6% -$5.45M 1.35% 27
2025
Q1
$91.4M Sell
408,406
-26,887
-6% -$6.02M 1.47% 21
2024
Q4
$143M Sell
435,293
-21,456
-5% -$7.03M 1.95% 14
2024
Q3
$137M Sell
456,749
-30,187
-6% -$9.06M 1.83% 16
2024
Q2
$160M Sell
486,936
-14,955
-3% -$4.93M 2.18% 9
2024
Q1
$199M Sell
501,891
-14,132
-3% -$5.59M 2.42% 10
2023
Q4
$182M Sell
516,023
-7,996
-2% -$2.82M 2.27% 11
2023
Q3
$197M Sell
524,019
-39,484
-7% -$14.8M 2.68% 7
2023
Q2
$216M Buy
563,503
+22,613
+4% +$8.65M 2.72% 6
2023
Q1
$187M Buy
540,890
+33,504
+7% +$11.6M 2.63% 8
2022
Q4
$119M Sell
507,386
-22,125
-4% -$5.21M 1.79% 18
2022
Q3
$130M Buy
529,511
+65,985
+14% +$16.2M 1.93% 15
2022
Q2
$140M Sell
463,526
-92,868
-17% -$28.1M 2.24% 8
2022
Q1
$229M Sell
556,394
-61,815
-10% -$25.4M 2.58% 7
2021
Q4
$290M Buy
618,209
+24
+0% +$11.3K 2.87% 3
2021
Q3
$262M Buy
618,185
+1,433
+0.2% +$608K 2.63% 4
2021
Q2
$221M Buy
616,752
+24,628
+4% +$8.84M 2.25% 7
2021
Q1
$167M Buy
592,124
+27,808
+5% +$7.84M 1.9% 12
2020
Q4
$160M Sell
564,316
-23,904
-4% -$6.77M 1.77% 19
2020
Q3
$162M Sell
588,220
-17,461
-3% -$4.8M 2.26% 10
2020
Q2
$138M Buy
605,681
+21,679
+4% +$4.92M 2.16% 11
2020
Q1
$88.9M Sell
584,002
-4,653
-0.8% -$708K 1.86% 17
2019
Q4
$88.5M Sell
588,655
-3,494
-0.6% -$525K 1.59% 22
2019
Q3
$84M Buy
592,149
+10,153
+2% +$1.44M 1.59% 23
2019
Q2
$72.8M Sell
581,996
-25,441
-4% -$3.18M 1.38% 28
2019
Q1
$66.9M Sell
607,437
-12,026
-2% -$1.33M 1.3% 27
2018
Q4
$60.7M Sell
619,463
-28,517
-4% -$2.8M 1.27% 27
2018
Q3
$80M Buy
647,980
+177,637
+38% +$21.9M 1.34% 27
2018
Q2
$46.7M Sell
470,343
-18,863
-4% -$1.87M 0.84% 48
2018
Q1
$43.2M Sell
489,206
-2,092
-0.4% -$185K 0.79% 49
2017
Q4
$48.5M Sell
491,298
-30,506
-6% -$3.01M 0.94% 39
2017
Q3
$50.2M Buy
521,804
+10,381
+2% +$999K 0.99% 40
2017
Q2
$48.3M Buy
+511,423
New +$48.3M 0.92% 45